Search results
COVID summer guide: How to navigate symptoms, variants and vaccines this season
Yahoo Life· 6 days ago“If you don’t feel right, you need to get a test,” says Smith. If your initial home test is...
Moderna stock is lone omen of bird flu pandemic
Reuters· 2 days agoThe recent rise of Moderna’s stock tells a grim tale. The $56 billion company which pioneered a Covid vaccine has seen its market value rise 40% since...
Moderna Stock (NASDAQ:MRNA): Is There Life Beyond Disease Outbreaks?
TipRanks via Yahoo Finance· 2 days agoModerna (NASDAQ:MRNA) stock has surged 40.8% since the turn of the year. Some of this momentum can...
Gateway - Quartz
Quartz· 1 day agoLike many other wealthy nations, the country bought many more vaccines than it needed—a total of nearly 32 million—to account for potential quality issues, or supply delays. This week, the nation ...
Feeling Sick After Your COVID Vaccine? According to Scientists, It’s Actually a Good Sign
SciTechDaily· 11 hours agoA UCSF study suggests that side effects like headaches and chills from COVID-19 vaccines indicate a...
Column: This GOP-leaning political polling firm has turned into a purveyor of anti-vaccine...
LA Times via Yahoo News· 17 hours agoBlaming the COVID vaccines for a tide of undocumented injuries and deaths is a popular theme in the...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 6 days agoIn 2020, the industry was thrust into the pandemic limelight as Pfizer and its partner BioNTech,...
How the largest public companies in Mass. performed in 2023 - Boston Business Journal
The Business Journals· 6 days agoWhich Massachusetts public companies had the best 2023? The restaurant tech provider has benefitted...
Novavax seeks FDA nod for updated COVID-19 vaccine By Investing.com
Investing.com· 5 days agoNovavax , Inc. (NASDAQ: NASDAQ:NVAX) has announced its submission for an amended Emergency Use...
GeoVax Receives BARDA Project NextGen Award to Conduct Phase 2b Clinical Study Evaluating the...
NewMediaWire via Yahoo Finance· 2 days ago10,000-participant randomized Phase 2b study will evaluate and compare GeoVax's multi-antigen,...